A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
Launched by THIRD MILITARY MEDICAL UNIVERSITY · Oct 1, 2007
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Grade 1 or 2 hypertension: 140mmHg≤SBP\<180mmHg, and/or 90mmHg≤DBP\<110mmHg
- • Waist circumference higher than 90cm in men, 80cm in women
- Exclusion Criteria:
- • Diabetes
- • Grade 3 hypertension: SBP≥180mmHg, or DBP≥110mmHg
- • known allergy or hypersensitivity to trial drugs
- • Myocardial infarction or cerebrovascular accident in the year preceding the trial
- • Clinical Congestive Heart Failure
- • History of hepatitis or cirrhosis
- • History of kidney disease
About Third Military Medical University
Third Military Medical University is a leading medical research institution located in China, renowned for its commitment to advancing healthcare through innovative clinical research and education. With a strong emphasis on military and civilian health, the university integrates cutting-edge scientific methodologies and interdisciplinary collaboration to enhance patient outcomes. Its robust clinical trial framework supports a diverse range of studies, fostering the development of new therapeutic interventions and contributing to the global body of medical knowledge. Through rigorous ethical standards and a focus on translational research, Third Military Medical University aims to address critical health challenges and improve community health on both local and international levels.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chongqing, , China
Patients applied
Trial Officials
Zhiming Zhu, MD, PhD
Principal Investigator
The third hospital affiliated to the Third Military Medical University. China
Zhiming Zhu, MD, PhD
Study Director
The third hospital affiliated to the Third Military Medical University. China
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials